MC2 Therapeutics
Privately held: no public share price
Assets
(2 total)
2Total Assets
1Approved
0Phase 3 / Filed
1Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Approved | Vitamin D receptor + Glucocorticoid receptorSmall molecule | Psoriasis | |
| Phase 2 | Topical dipeptide (alanyl-glutamine)Small molecule | Chronic Kidney Disease |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.